2023 - Research.com Medicine in Canada Leader Award
2010 - Fellow of the Royal Society of Canada Academy of Science
His primary areas of study are Asthma, Immunology, Internal medicine, Inhalation and Anesthesia. His studies in Asthma integrate themes in fields like Placebo, Methacholine, Randomized controlled trial and Physical therapy. His Physical therapy research incorporates elements of MEDLINE, Intensive care medicine, Global health, Asthma Control Questionnaire and Risk factor.
His Immunology research focuses on Airway and how it relates to Bronchoalveolar lavage. Paul M. O'Byrne has researched Internal medicine in several fields, including Gastroenterology and Endocrinology. His study in Budesonide is interdisciplinary in nature, drawing from both Exacerbation and Bronchodilator.
Asthma, Immunology, Internal medicine, Inhalation and Anesthesia are his primary areas of study. His work in Asthma addresses issues such as Methacholine, which are connected to fields such as Provocation test. His Immunology course of study focuses on Airway and Bronchoalveolar lavage.
His studies deal with areas such as Gastroenterology and Endocrinology as well as Internal medicine. The study incorporates disciplines such as Bronchodilator and Crossover study in addition to Anesthesia. His Budesonide research includes elements of Exacerbation, Terbutaline and Physical therapy.
Paul M. O'Byrne focuses on Asthma, Immunology, Internal medicine, Allergen and Placebo. His Asthma research is multidisciplinary, incorporating elements of Crossover study, Anesthesia, Airway and Methacholine. Paul M. O'Byrne works mostly in the field of Internal medicine, limiting it down to topics relating to Gastroenterology and, in certain cases, Exhaled nitric oxide, as a part of the same area of interest.
His study on Allergen also encompasses disciplines like
His primary areas of study are Asthma, Immunology, Anesthesia, Internal medicine and Allergen. His Asthma research is multidisciplinary, incorporating perspectives in Placebo, Inhalation, Airway and MEDLINE. His research integrates issues of Global health, Physical therapy, Family medicine and Intensive care medicine in his study of MEDLINE.
Paul M. O'Byrne has included themes like Biomarker, Interquartile range, Adverse effect and Methacholine in his Anesthesia study. His work is dedicated to discovering how Internal medicine, Gastroenterology are connected with Bronchial hyperresponsiveness and other disciplines. Paul M. O'Byrne has researched Allergen in several fields, including Gene expression, DNA methylation, Eosinophilia, Myeloid and Bone marrow.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Tissue plasminogen activator for acute ischemic stroke. The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group.
JC Grotta;M Kothari;Kma Welch.
The New England Journal of Medicine (1995)
Global strategy for asthma management and prevention: GINA executive summary.
Bateman Ed;Hurd Ss;Barnes Pj;Bousquet J.
European Respiratory Journal (2008)
Development and validation of a questionnaire to measure asthma control
E. F. Juniper;P. M. O'Byrne;G. H. Guyatt;P. J. Ferrie.
European Respiratory Journal (1999)
Effect of inhaled formoterol and budesonide on exacerbations of asthma. Formoterol and Corticosteroids Establishing Therapy (FACET) International Study Group
Romain A. Pauwels;Claes-Göran Löfdahl;Dirkje S. Postma;Anne E. Tattersfield.
The New England Journal of Medicine (1997)
Airway Responsiveness. Standardized Challenge Testing With Pharmacological, Physical and Sensitizing Stimuli in Adults. Report Working Party Standardization of Lung Function Tests, European Community for Steel and Coal. Official Statement of the European Respiratory Society
P. J. Sterk;Leonardo Fabbri;P. H. Quanjer;D. W. Cockcroft.
The European respiratory journal. Supplement (1993)
Mepolizumab for Prednisone-Dependent Asthma with Sputum Eosinophilia
Parameswaran Nair;Marcia M M Pizzichini;Melanie Kjarsgaard;Mark D Inman.
The New England Journal of Medicine (2009)
An official American Thoracic Society/European Respiratory Society statement: asthma control and exacerbations: standardizing endpoints for clinical asthma trials and clinical practice.
Helen K. Reddel;D. Robin Taylor;Eric D. Bateman;Louis-Philippe Boulet.
American Journal of Respiratory and Critical Care Medicine (2009)
Treatment of Asthma with Drugs Modifying the Leukotriene Pathway
Jeffrey M. Drazen;Elliot Israel;Paul M. O'Byrne.
The New England Journal of Medicine (1999)
Managing Cough as a Defense Mechanism and as a Symptom: A Consensus Panel Report of the American College of Chest Physicians
Richard S. Irwin;Louis-Philipe Boulet;Michelle M. Cloutier;Richard Fuller.
Chest (1998)
Early intervention with budesonide in mild persistent asthma: a randomised, double-blind trial
Romain A Pauwels;Søren Pedersen;William W Busse;Wan C Tan.
The Lancet (2003)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:
McMaster University
McMaster University
McMaster University
University of Cape Town
Université Laval
University of Saskatchewan
McMaster University
University of British Columbia
University of Wisconsin–Madison
McMaster University
Texas A&M University
The University of Texas at Austin
Hunan University
Hoshi University
York University
University of California, Los Angeles
Jilin University
University College London
Medical University of Vienna
National Scientific and Technical Research Council
Nanjing University
University of Florida
Wayne State University
National Institutes of Health
Washington University in St. Louis
University of Copenhagen